Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients

<p>Introduction: Acute graft-versus-host disease (aGvHD) is a potentially life-threatening complication that can occur following allogeneic haematopoietic stem cell transplantation. Although corticosteroids remain the standard first-line therapy, a considerable number of patients fail to...

Полное описание

Библиографические подробности

Главные авторы:	Robert Zeiser, Halvard Bönig, Elena Osswald, Uwe Pichlmeier, Ann-Kristin Möller, Michael Tribanek, Maria Lazarou-Wild, Renate von der Weth, Lisa-Marie Pfeffermann, Peter Bader
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Karger Publishers 2026-01-01
Серии:	Transfusion Medicine and Hemotherapy
Online-ссылка:	https://karger.com/article/doi/10.1159/000550469
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!